We are live on ! Find out more
KCPG

Kavar Capital Partners Group Portfolio holdings

AUM $812M
1-Year Est. Return 29.76%
This Fund
S&P 500
This Quarter Est. Return
-6.2%
1 Year Est. Return
+29.76%
3 Year Est. Return
+77.21%
5 Year Est. Return
+92.54%
10 Year Est. Return
+280.51%
AUM
$392M
AUM Growth
-$39M
Cap. Flow
-$9.37M
Cap. Flow %
-2.39%
Top 10 Hldgs %
35.27%
Holding
169
New
5
Increased
65
Reduced
37
Closed
30

Sector Composition

Rank Sector Weight
1 Healthcare 17.97%
2 Technology 12.49%
3 Consumer Staples 10.57%
4 Financials 10.06%
5 Consumer Discretionary 6.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FDX icon
51
FedEx
FDX
$73.5B
$2.34M 0.6%
15,735
+5,019
+47% +$1.06M
EW icon
52
Edwards Lifesciences
EW
$51.2B
$2.26M 0.58%
27,351
+209
+0.8% +$20.1K
ANET icon
53
Arista Networks
ANET
$248B
$2.25M 0.57%
79,660
+1,340
+2% +$38.6K
SYY icon
54
Sysco
SYY
$40.3B
$2.22M 0.57%
31,432
-99
-0.3% -$8.24K
ADP icon
55
Automatic Data Processing
ADP
$107B
$2.21M 0.56%
9,752
GFF icon
56
Griffon
GFF
$4.72B
$2.18M 0.56%
73,809
CAT icon
57
Caterpillar
CAT
$401B
$2.15M 0.55%
13,097
+9,649
+280% +$1.76M
SO icon
58
Southern Company
SO
$107B
$2.11M 0.54%
31,039
+4,084
+15% +$309K
KO icon
59
Coca-Cola
KO
$374B
$2.04M 0.52%
36,349
ARCC icon
60
Ares Capital
ARCC
$13.9B
$2.01M 0.51%
119,158
+35,949
+43% +$695K
VTV icon
61
Vanguard Morningstar Value ETF
VTV
$191B
$1.97M 0.5%
15,975
BAX icon
62
Baxter International
BAX
$14.1B
$1.9M 0.48%
35,180
-2,002
-5% -$120K
GSK icon
63
GSK
GSK
$103B
$1.78M 0.45%
+60,510
New +$2.29M
MU icon
64
Micron Technology
MU
$1.01T
$1.78M 0.45%
35,445
-220
-0.6% -$12.8K
CFB
65
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
$1.61M 0.41%
123,240
XOM icon
66
ExxonMobil
XOM
$628B
$1.59M 0.41%
18,272
-298
-2% -$27.2K
PM icon
67
Philip Morris
PM
$294B
$1.57M 0.4%
18,884
-279
-1% -$26.6K
PFE icon
68
Pfizer
PFE
$147B
$1.51M 0.39%
34,606
-500
-1% -$24.3K
IWM icon
69
iShares Russell 2000 ETF
IWM
$82.5B
$1.46M 0.37%
8,861
-164
-2% -$29.9K
MO icon
70
Altria Group
MO
$114B
$1.44M 0.37%
35,642
+1,375
+4% +$60K
MRK icon
71
Merck
MRK
$317B
$1.39M 0.35%
16,082
-1,147
-7% -$102K
BP icon
72
BP
BP
$106B
$1.38M 0.35%
48,290
+22,540
+88% +$671K
IRM icon
73
Iron Mountain
IRM
$37.8B
$1.3M 0.33%
29,473
-1,275
-4% -$64.4K
FOCS
74
DELISTED
Focus Financial Partners Inc. Class A
FOCS
$1.26M 0.32%
39,935
DFUS
75
Dimensional US Equity ETF
DFUS
$21.5B
$1.24M 0.32%
32,051
+127
+0.4% +$5.46K

Similar funds

Kavar Capital Partners Group's Q3 2022 Portfolio in Review

As of Q3 2022, Kavar Capital Partners Group held 169 positions worth $392M, down 9.1% from $431M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Kavar Capital Partners Group's Q3 2022 filing shows 5 new, 65 increased, 37 reduced and 30 closed positions. Its largest new stake was GSK: 60,510 shares worth $1.78M. The largest sale was JPMorgan Inflation Managed Bond ETF, an estimated $7.32M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Staples.

  • Kavar Capital Partners Group's largest Q3 2022 buy was GSK: 60,510 shares worth $1.78M.
  • Kavar Capital Partners Group added most to Schwab Fundamental US Large Company Index ETF in Q3 2022, an estimated $2.19M increase.
  • Kavar Capital Partners Group's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $1.27M.
  • Kavar Capital Partners Group fully exited JPMorgan Inflation Managed Bond ETF in Q3 2022, selling an estimated $7.32M.
  • Kavar Capital Partners Group's ten largest holdings make up 35% of its $392M portfolio in Q3 2022.
  • Kavar Capital Partners Group opened 5 new positions and closed 30 in Q3 2022.
  • Kavar Capital Partners Group's portfolio value fell 9.1% quarter-over-quarter to $392M.

Based on Kavar Capital Partners Group's 13F filing for Q3 2022, filed 8 Nov 2022.